AZ closes in Forxiga kidney disease label in EU after nod from CHMPAstraZeneca’s fast-growing SGLT2 inhibitor Forxiga could soon get a further boost from approval in the EU as a Share XAZ closes in Forxiga kidney disease label in EU after nod from CHMPhttps://pharmaphorum.com/news/az-closes-in-forxiga-kidney-disease-label-in-eu-after-nod-from-chmp/
CHMP backs bluebird bio’s gene therapy for rare disease ALDUS biotech bluebird bio has had a challenging time in the last few months, so a recommendation for Share XCHMP backs bluebird bio’s gene therapy for rare disease ALDhttps://pharmaphorum.com/news/chmp-backs-bluebird-bios-gene-therapy-for-rare-disease-ald/
CHMP backs Roche’s Enspryng for rare nerve disease NMOSDRoche’s Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending Share XCHMP backs Roche’s Enspryng for rare nerve disease NMOSDhttps://pharmaphorum.com/news/chmp-backs-roches-enspryng-for-rare-nerve-disease-nmosd/
CHMP backs Celltrion’s regdanvimab antibody for COVID-19The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human Share XCHMP backs Celltrion’s regdanvimab antibody for COVID-19https://pharmaphorum.com/news/chmp-backs-celltrions-regdanvimab-antibody-for-covid-19/
J&J’s COVID-19 shot backed for emergency use in EUThe EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot Share XJ&J’s COVID-19 shot backed for emergency use in EUhttps://pharmaphorum.com/news/jjs-covid-19-shot-backed-for-emergency-use-in-eu/
EMA backs emergency use of Lilly’s COVID antibodiesThe EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who Share XEMA backs emergency use of Lilly’s COVID antibodieshttps://pharmaphorum.com/news/ema-backs-emergency-use-of-lillys-covid-antibodies/
CHMP clears way for EU approval of Novartis’ MS drugNovartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, Share XCHMP clears way for EU approval of Novartis’ MS drughttps://pharmaphorum.com/news/chmp-clears-way-for-eu-approval-for-novartis-ms-drug/
EMA approves AZ’s COVID-19 vaccine – including for over-65sThe EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18, Share XEMA approves AZ’s COVID-19 vaccine – including for over-65shttps://pharmaphorum.com/news/ema-approves-azs-covid-19-vaccine-including-for-over-65s/
Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancerDaiichi Sankyo and AstraZeneca could be just weeks away from an EU approval for their antibody-drug conjugate (ADC) Share XDaiichi Sankyo, AZ close on EU approval of Enhertu for breast cancerhttps://pharmaphorum.com/news/daiichi-sankyo-az-close-on-eu-approval-of-enhertu-for-breast-cancer/
